John Kim

$RKLB Covered Call Sell Alert I just sold $RKLB Jan 10, 2027 covered calls at a $145 strike for $11/share premium. This brings the average cost of my newly acquired shares down to ~$55. For context, I previously held 10,000 shares at around a $15 average and exited in the mid-$80s in January. I also sold 20 of the same covered calls in my 401(k) across all shares there. This position represents ~20% of the shares in my individual account. I plan to continue selling more covered calls as the price moves higher. Ideally, I would prefer April 2027 expiries so that, if assigned, my shares qualify for long-term capital gains treatment. Those aren’t available yet — once they are, I plan to roll into them. Rationale: While I believe Rocket Lab is one of the best companies out there, led by a standout founder/CEO (as outlined in my investment thesis), a significant portion of the upside — especially the key catalyst Neutron — appears to be priced in. If my shares are called away, I’d effectively be exiting at roughly an ~$85B market cap ($155/share) on less than $1B in annual revenue. Great businesses can still be poor investments if bought at the wrong valuation. At ~60–70x trailing revenue, I think some de-risking is warranted. I’m here to make money — not to hold shares indefinitely.